This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC

Latest News

Subpage Hero


09 Sep 2021

Should age impact on how we manage hypertension?

Should age impact on how we manage hypertension?

A familiar dilemma in the day of a clinical pharmacist'

NICE recommends ACE inhibitors are used first-line to management of hypertension in those <55y, and calcium channel blockers (CCBs) in those ?55y (once diabetes and ethnicity are taken into account).

However, a UK cohort study showed that:

  • In those who were not black, not diabetic and <55y there was no significant difference in BP control between ACE inhibitors or CCBs at 12 months.
  • CCBs did seem to have greater BP-lowering effects in those over 75y.

What about BP targets in our frail patients?

A UK observational study showed that:

  • In those over 85y, raised blood pressure was not associated with increased mortality (even if SBP >180!).
  • In those aged 75'85y:
    • If moderately'severely frail, there was NO association between raised BP and mortality.
    • If mildly frail, raised blood pressure WAS associated with increased mortality.
    • Having too low a blood pressure was also harmful: in those ?75y, BP <130/80 was associated with an increased risk of all-cause mortality.

What does this mean in practice?

Guidelines are written for populations, and if there is a good reason to deviate from them then we are free to do that (remember to document your reasoning!).

  • We can think more about comorbidities when choosing which drug to use; hypertension + proteinuria = consider ACE inhibitor, hypertension + CVA = consider CCB.
  • Don't be afraid to adjust blood pressure targets people as become more frail.

Found this snippet useful? Red Whale runs one-day Clinical Pharmacist Update Courses, packed with updates like this, and has provided general update, cancer and MSK/chronic pain education (both face to face and online) to over 4000 pharmacists over the past five years through our longstanding relationship with CPPE.




Lead Education Partner

  • CPPE
  • Morph


Education Partner

  • BOPA
  • BPNG
  • CMHP
  • Health Education England


Education Partner

  • NHS England and NHS Improvement
  • NHS Digital
  • NHSx
  • PTOC
  • GPHC


Education Partner

  • NPPG
  • PCPA
  • PDA
  • Pharmacist Support
  • RPUK
  • SPS


Education Partner

  • Soar Beyond
  • NHCA
  • PrescQIPP
  • Pharmacy Declares
  • GHP and RPS


Media Partner

  • C&D
  • PDA
  • PrescQIPP
  • Scottish Healthcare Review
  • Welsh Healthcare Review
  • NI Healthcare Review
  • Prescriber


Nominated Charity

  • Pharmacist Support


Newsletter Sign Up